---
{"dg-publish":true,"permalink":"/USMLE/GI/Primary sclerosing cholangitis/"}
---

# Epidemiology
- Sex: ♂ > ♀ (2:1)
- Age: The median age at diagnosis is ∼ 40.

>[!tip] 
>Compared with [[USMLE/GI/Primary biliary cholangitis\|Primary biliary cholangitis]], which are common among middle-aged women.

---
# Etiology
- The exact cause is unknown.
- Associations
	- Chronic inflammatory bowel diseases (IBD)
		- ∼ 90% of patients with PSC have IBD (approx. 87% of these patients have [[USMLE/GI/Ulcerative colitis\|ulcerative colitis]])
	- Presence of HLA-B8 and HLA-DR3
 
 >[!tip] 
>The majority of patients with PSC also have [[USMLE/GI/Ulcerative colitis\|ulcerative colitis]].

---
# Pathophysiology
Progressive chronic inflammation of <span style="background:rgba(240, 200, 0, 0.2)">both intrahepatic and extrahepatic bile ducts</span>

---
# Clinical features
- Signs of cholestasis
	- Jaundice/scleral icterus
	- Pruritus
	- Pale stool, dark urine
	- Fatigue
	- Can lead to acute cholangitis (fever, chills, right upper quadrant pain)
- Later stages: signs of [[USMLE/GI/Cirrhosis\|cirrhosis]]
	- Hepatosplenomegaly
	- Portal hypertension
	- Liver failure
- Symptoms of chronic inflammatory bowel disease, which is frequently associated with PSC, or other associated comorbidities

---
# Diagnostics

<div class="transclusion internal-embed is-loaded"><a class="markdown-embed-link" href="/USMLE/REVIEW/Autoimmune Liver Diseases/" aria-label="Open link"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a><div class="markdown-embed">





| Feature          | Primary Sclerosing Cholangitis (PSC)                                                      | Primary Biliary Cholangitis (PBC)                                                     | Autoimmune Hepatitis (AIH)                                                 |
| :--------------- | :---------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------ | :------------------------------------------------------------------------- |
| **Patho**        | Inflammation/fibrosis of **intra- & extrahepatic** bile ducts                             | Autoimmune destruction of **intrahepatic** bile ducts                                 | Autoimmune destruction of **hepatocytes**                                  |
| **Epi / Assoc.** | **M** > F (2:1), <40s<br>Assoc: **[[USMLE/GI/Ulcerative colitis\|Ulcerative Colitis]] (IBD)** (>80%)                       | **F** >> M (9:1), 40-60s<br>Assoc: **Sjögren's**, other autoimmune dz                 | **F** > M (3:1), bimodal (young/middle-aged)<br>Assoc: Other autoimmune dz |
| **Labs**         | Cholestatic: **↑↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]]**, ↑ GGT                                                            | Cholestatic: **↑↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]]**, ↑ GGT                                                        | Hepatocellular: **↑↑↑ AST/ALT** (>1000s common), ↑ IgG                     |
| **Serology**     | **(+) [[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|p-ANCA]]**                                                                            | **(+) AMA** (Anti-Mitochondrial Ab)                                                   | **(+) ANA**, **(+) ASMA** (Anti-Smooth Muscle Ab)                          |
| **Dx / Histo**   | **MRCP/ERCP**: **"Beads on a string"**<br>Histo: **"Onion skinning"** periductal fibrosis | Normal imaging<br>Histo: **Florid duct lesion** (lymphocytic cholangitis, granulomas) | Normal/nonspecific imaging<br>Histo: **Interface hepatitis**, plasma cells |
| **Tx**           | Symptomatic Tx; Liver transplant (definitive)                                             | **Ursodeoxycholic acid (UDCA)**                                                       | **[[USMLE/Pharmacology/Corticosteroids\|Corticosteroids]]**, Azathioprine                                          |
| **Key Risk**     | **Cholangiocarcinoma**, [[USMLE/GI/Colorectal cancer\|Colorectal Cancer]] (w/ [[USMLE/GI/Ulcerative colitis\|UC]])                                         | [[USMLE/MSK/Osteoporosis\|Osteoporosis]], [[USMLE/GI/Cirrhosis\|Cirrhosis]], HCC                                                          | [[USMLE/GI/Cirrhosis\|Cirrhosis]], Acute Liver Failure                                             |

![Pasted image 20231016163207.png](/img/user/appendix/Pasted%20image%2020231016163207.png)


</div></div>


- Cholestatic enzymes
	- ↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]]
	- ↑ GGT
	- Normal or ↑ conjugated bilirubin 
- Transaminases: normal or moderately elevated (approx. 2–3× ULN) AST and ALT  
- Lipid profile: ↑ total cholesterol

>[!Mnemonic] 
>Suspect PSC in patients with a history of inflammatory bowel disease and elevated cholestatic enzymes ([[USMLE/Blood/Alkaline phosphatase\|ALP]], GGT, and conjugated bilirubin).

- Typical perinuclear anti-neutrophil cytoplasmic antibodies (<span style="background:rgba(240, 200, 0, 0.2)">pANCA</span>): present in up to 80% of patients with PSC.
## Magnetic resonance cholangiopancreatography 
- Method of choice (if there is no biliary obstruction)
- Supportive findings: <span style="background:rgba(240, 200, 0, 0.2)">multifocal intrahepatic and extrahepatic bile duct strictures alternating with dilatation and beading of bile ducts</span>![Pasted image 20231017161356.png](/img/user/appendix/Pasted%20image%2020231017161356.png)There is irregular dilatation (green overlay) of intrahepatic bile ducts proximal to a common duct stenosis (arrow). Alternation of strictured and dilated segments creates a beaded appearance. Peripheral ducts appear pruned as a result of obliteration (examples indicated by arrowheads), and scattered biliary diverticula are seen (example indicated by red overlay).

# Differential Diagnosis
![Pasted image 20231017161223.png](/img/user/appendix/Pasted%20image%2020231017161223.png)

---
# Treatment


---
# Complications
- Cholangiocarcinoma (∼ 10–15% of cases)
